Evidence map›Paper›PMID 37250174›Full record

ArticleOpen forum infectious diseases2023

Prevalence of SARS-CoV-2 Viremia in Presymptomatic Blood Donors in the Delta and Omicron Variant Eras.

Paula Saá, Rebecca V Fink, Hina Dawar, Clara Di Germanio, Leilani Montalvo, David J Wright, David E Krysztof, Steven H Kleinman, Theresa Nester, Debra A Kessler and 9 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Open forum infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 8 institutions in 2 countries.

Paula SaáScientific Affairs, American Red Cross, Rockville, Maryland, USA.
Rebecca V FinkWestat, Rockville, Maryland, USA.
Hina DawarVitalant Research Institute, San Francisco, California, USA.
Clara Di GermanioVitalant Research Institute, San Francisco, California, USA.
Leilani MontalvoVitalant Research Institute, San Francisco, California, USA.
David J WrightWestat, Rockville, Maryland, USA.
David E KrysztofScientific Affairs, American Red Cross, Rockville, Maryland, USA.
Steven H KleinmanUniversity of British Columbia, Victoria, British Columbia, Canada.
Theresa NesterBloodworks Northwest, Seattle, Washington, USA.
Debra A KesslerNew York Blood Center Enterprises, New York, New York, USA.
Rebecca L TownsendScientific Affairs, American Red Cross, Rockville, Maryland, USA.
Bryan R SpencerScientific Affairs, American Red Cross, Rockville, Maryland, USA.
Hany KamelVitalant, Scottsdale, Arizona, USA.
Jackie VannoyVitalant, Scottsdale, Arizona, USA.
Michael P BuschVitalant Research Institute, San Francisco, California, USA.
Susan L StramerScientific Affairs, American Red Cross, Rockville, Maryland, USA.
Mars StoneVitalant Research Institute, San Francisco, California, USA.ORCID https://orcid.org/0000-0001-5619-2767
Philip J NorrisVitalant Research Institute, San Francisco, California, USA.ORCID https://orcid.org/0000-0003-0526-2088
NHLBI Recipient Epidemiology and Donor Evaluation Study-IV-Pediatric (REDS-IV-P)
American Red Cross · USUniversity of California, San Francisco · USPacific Research Institute · USVitalant · USWestat (United States) · USBloodworks Northwest · USNew York Blood Center · USUniversity of British Columbia · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Presymptomatic plasma samples from 1596 donors reporting coronavirus disease 2019 infection or symptoms after blood donation were tested for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA and anti-S and anti-N antibodies. Prior infection and vaccination both protected from developing SARS-CoV-2 RNAemia and from symptomatic infection. RNAemia rates did not differ in the Delta and Omicron variant eras.

Indexed as

COVID-19vaccinationviremia

Identifiers

PMID37250174
PMCPMC10220507
OpenAlexW4378745891

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.